Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-21-053520)

Filing Details

Accession Number:: 0001209191-21-053520
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-08-26 17:51:54
Reporting Period:: 2021-08-25

Accepted Time:: 2021-08-26 17:51:54
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1637715	Reneo Pharmaceuticals Inc.	RPHM	Pharmaceutical Preparations (2834)	472309515

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1854179	Michael Cruse	C/O Reneo Pharmaceuticals, Inc. 18575 Jamboree Road, Suite 275-S Irvine CA 92612	Senior Vp-Corporate Operations	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-08-25	2,500	$7.45	2,500	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The weighted average purchase price for the transaction was $7.4464. The shares were purchased at a range of prices between $7.425 and $7.45. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.